摘要:
A method for producing compounds of formula (I) in which the radical R1 is selected from —NH2, —NH2-z Az, and monovalent alkyl and aryl radicals, the radicals A are selected in each case independently of one another from the phosphoryl radicals DOPO—, DPhPO— and DPhOPO—, and the indices x, y and z, in each case independently of one another, stand for 0 or 1, wherein at least one of the indices is ≠0, by reacting, in a first step, melamine or, when R1 is an alkyl or aryl radical, the corresponding alkyl or aryl guanamine, with one or more of the corresponding phosphinyl chlorides DOP—CI, DPhP—Cl and DPhOP—CI, in order to bond one or more phosphinyl radicals to the amino groups(s) of the melamine or guanamine, and in a second step oxidising the phsophinyl radical(s) by reaction with an oxidising agent to give the corresponding phosphoryl radical(s).
摘要翻译:式(I)化合物的方法,其中基团R 1选自-NH 2,-NH 2 -z Z a和一价烷基和芳基,基团A在每种情况下彼此独立地选自磷酰基 DOPO-,DPhPO-和DPhOPO-,并且指数x,y和z在每种情况下彼此独立地代表0或1,其中指数中的至少一个≠0,通过在第一步骤 ,三聚氰胺,或者当R1是烷基或芳基时,相应的烷基或芳基胍胺与一种或多种相应的氧化膦氯化物DOP-Cl,DPhP-Cl和DPhOP-Cl结合,以便键合一个或多个氧膦基 与三聚氰胺或胍胺的氨基反应,并且在第二步中通过与氧化剂反应氧化所述phphphinyl基团以产生相应的磷酰基。
摘要:
The present invention relates to methods, compounds, and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses, and is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention also relates to compounds that inhibit smooth muscle proliferation, for example, by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis. This invention also relates to medical devices, such as a stent, comprising a compound or composition of this invention disposed on or within the medical device.
摘要:
The high-nitrogen compound of the formula was prepared. Pyrolysis of the compound yields carbon nitrides C2N3 and C3N5. The carbon nitrides vary in their density, texture, and morphology.
摘要:
The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.
摘要:
A process for the production of a high energy nitrate ester involves reacting, in an inert organic solvent, a heterocyclic compound, selected from oxiranes, oxetanes, N-substituted aziridines and N-substituted azetidines, with either N.sub.2 O.sub.4 or N.sub.2 O.sub.5, and when the compound is reacted with N.sub.2 O.sub.4, oxidizing the O- or N-nitrate substituents or substituent in the product to O- or N-nitrate substituent or substituents. The remaining ring carbon atoms on the heterocyclic compound may be substituted or unsubstituted. Preferred substituent groups for the C and/or N ring atoms on the compound include alkyl, cyanoalkyl, haloalkyl, nitroalkyl, and substituted aryl.Several novel nitrate ester are also provided, including nitrated derivatives of polybutadiene, in which between 1% and 25% of the carbon atoms in the polymer are substituted by vicinal nitrate ester (--ONO.sub.2) groups.
摘要翻译:制备高能硝酸酯的方法包括在惰性有机溶剂中使选自环氧乙烷,氧杂环丁烷,N-取代的氮丙啶和N-取代的氮杂环丁烷与杂环化合物与N 2 O 4或N 2 O 5反应,当化合物 与N2O4反应,将产物中的O-或N-硝酸盐取代基或取代基氧化成O-或N-硝酸盐取代基。 杂环化合物上的剩余环碳原子可以是取代或未取代的。 化合物上C和/或N环原子的优选取代基包括烷基,氰基烷基,卤代烷基,硝基烷基和取代的芳基。 还提供了几种新的硝酸酯,包括聚丁二烯的硝化衍生物,其中聚合物中1%至25%的碳原子被连位硝酸酯(-ONO 2)基团取代。
摘要:
Novel melamine-poly(oxyethylene or oxypropylene) diamine condensates are prepared which have the formula: ##STR1## Wherein: R represents H or--NH--CHR'--(CH.sub.2).sub.x --[--O--CH.sub.2 --CHR"--].sub.n --O--(CH.sub.2).sub.x --CHR'--NH.sub.2R' represents H or --CH.sub.3,R" represents H or -CH.sub.3 or CH.sub.2 CH.sub.3,x represents an integer having a value of 1 or 2, andn is a number having an average value of about 1 to about 2.The melamine-poly(oxyethylene or oxypropylene) diamine condensates have utility as curing agents for epoxy resins.
摘要:
A process for preparing trichloromelamine starting from chlorine and melamine, with intermediate formation of an aqueous suspension of hexachloromelamine, characterized in that hexachloromelamine is solubilized by addition of a water-immiscible solvent, the aqueous phase is separated and the hexachloromelamine solution is brought into contact, in the presence of an activator, with a number of melamine moles which is equal to or lower than the number of moles of the remaining hexachloromelamine.